Liquid Biopsy Market Size To Grow By USD 4.79 Bn By 2028 With 20.2% | F. Hoffmann-La Roche Ltd. (Switzerland), Angle Plc (UK), BIOCEPT Inc. (The US)

Market Overview:
Global Liquid Biopsy Market was valued at USD 1.32 billion in 2021 and is expected to reach USD 4.79 billion by the year 2028, at a CAGR of 20.2%.

A liquid biopsy is a non-invasive and simple alternative to surgical biopsies that allows doctors to learn about tumors from a simple blood sample. In 1994, scientists achieved the ability to detect specific mutations in cfDNA. In 1997, Dennis Lo discovered fetal cfDNA in blood, and in 2000, Veridex released the first commercially available liquid biopsy assay, the CELL SEARCH CTC test. In June 2016, the FDA approved the Cobas EGFR Mutation Test as a cfDNA test for the EGFR gene mutation in lung cancer patients' blood.

Read More About This Report:
https://introspectivemarketresearch.com/reports/liquid-biopsy-market/

Market Dynamics:
Driver:
Cancer remains one of the world's leading causes of morbidity and mortality. According to the WHO, cancer is the world's second leading cause of death. The International Agency for Research on Cancer (IARC) estimates that the global cancer burden will reach 19.3 million cases and 9.96 million cancer deaths in 2020. Liquid Biopsy is a non-invasive cancer diagnostic technique that has emerged. A test's results are usually available much faster than the results of a standard tissue biopsy. This has helped cancer diagnosis an easy task as individuals in early stage can be screened and thus offered medical aid to restrict the growth of the cancer.

Opportunities:
Companion diagnostics are tests or assays that assist physicians in making treatment decisions for patients based on the best response to therapy. Co-development of companion diagnostics with therapeutic products has the potential to significantly alter the drug development process and accelerate the commercialization of drug candidates by rapidly and cost-effectively producing safer drugs with improved therapeutic efficacy. Due to the increased demand for high-priced specialist therapies and safer drugs, the market for companion diagnostics has a high growth potential.

Get a Sample PDF of the Report@
https://introspectivemarketresearch.com/request/16300

Market Segmentation
Segmentation Analysis Of Liquid Biopsy Market
By cancer type, the lung cancer segment is forecasted to dominate the liquid biopsy market in the upcoming future. Lung cancer is the most common type of cancer diagnosed through a liquid biopsy. Liquid biopsy is a new technology that could aid in the screening and early detection of lung cancer.

By circulating biomarkers, circulating tumor DNA is expected to be the fastest-growing segment during the forecast period due to the rapid development of next-generation sequencing (NGS) technologies in liquid biopsy advancements applied to circulating tumor DNA (ctDNA).

By End-users, the hospital segment is expected to have the highest share of the liquid biopsy market in the projected timeframe was dominated by the hospital segment. The growth of the liquid biopsy market can be attributed to the increased use of liquid biopsy tests in hospitals and laboratory settings, which are the preferred healthcare facilities for patients.

By Cancer Type
• Lung
• Breast
• Liver
• Others

By Circulating Biomarker
• Circulating Tumor DNA
• Circulating Tumor Cells
• Others

By End-User
• Hospitals
• Laboratories
• Government Research Centre

For More Information or Query or Customization before buying, Visit at
https://introspectivemarketresearch.com/inquiry/16300

Regional Analysis Of Liquid Biopsy Market
The North American region is anticipated to have the highest share of the liquid biopsy market in the forecast period due to the growing awareness about the diagnosis of cancer in this region. The large share of this regional segment can be attributed to the ease of access to technologically advanced instruments, the highly developed healthcare systems in the United States and Canada, and the presence of many leading national clinical research laboratories. Cancer affects approximately one in every five Canadians and kills approximately one in every four. In 2021, an estimated 229 200 Canadians will be diagnosed with cancer and 84 600 will die from cancer.

By Region
• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
• Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
• South America (Brazil, Argentina, Rest of SA)

Who Are The Top Key Players Operating The Global Liquid Biopsy Market:
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Myriad Genetics Inc. (US)
• QIAGEN N.V. (Netherlands)
• Thermo Fisher Scientific Inc. (the US)
• Guardant Health Inc. (the US)
• BIOCEPT Inc. (the US)
• Illumina Inc. (the US)
• Angle plc (UK)
• Oncimmune(UK)
• Lucence health Inc. (US)
• FreenomeHoldings Inc. (US) and Other Major Players.

Key Industry Development In The Liquid Biopsy Market
• In July 2021, Biocept, Inc. was awarded a South Korean Patent for its Primer-Switch technology, which detects rare mutations in circulating tumor DNA (ctDNA) using real-time PCR and associated analysis methods.
• In March 2021, Lucence announced a partnership with Waseda University in Japan to develop a unique high-speed liquid biopsy laser-based imaging platform for early cancer detection.
• In February 2021, Guardant Health, Inc. announced the supply of Guardant Reveal, the primary blood-only liquid biopsy test for the detection of residual and recurrent disease from an easy blood draw.

Up-To Avail 20% Discount on various license types on immediate purchase (Use corporate email ID). Get Higher Priority-
https://introspectivemarketresearch.com/discount/16300

Table of Content:
Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
 3.1 By Cancer Type
 3.2 By Circulating Biomarker
 3.3 By End-User
Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing
Chapter 5: Liquid Biopsy Market by Cancer Type
 5.1 Liquid Biopsy Market Overview Snapshot and Growth Engine
 5.2 Liquid Biopsy Market Overview
 5.3 Lung Cancer
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Lung Cancer: Grographic Segmentation
 5.4 Breast Cancer
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Breast Cancer: Grographic Segmentation
 5.5 Liver Cancer
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Liver Cancer: Grographic Segmentation
 5.6 Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Others: Grographic Segmentation
To Be Continued........

Purchase This Report@
https://introspectivemarketresearch.com/checkout/?user=1&_sid=16300

For More Related Reports Click Here:
https://introspectivemarketresearch.com/reports/interstitial-lung-disease-treatment-market/
https://introspectivemarketresearch.com/reports/liver-cancer-diagnostics-market/
https://introspectivemarketresearch.com/reports/breast-biopsy-localization-wire-market/

Contact us:
Introspective Market Research
3001 S King Drive,
Chicago, Illinois
60616 USA
Ph no: +1-773-382-1047
Email : sales@introspectivemarketresearch.com
LinkedIn | Twitter | Facebook

About us:
Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

This release was published on openPR.